General contact

Main switchboard

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST


Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999


Investor Relations

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Corporate publications

Download or order key corporate publications using the tabs below. The Annual Report and 20-F contain our complete audited financial statements.

Please fill in all mandatory fields marked with an asterisk (*)

Step 1: Select publications to order

Please select the publication to order

Annual Report 2013

Novartis Venture Fund
Activity Report

Novartis Swiss Passport

Step 2: Enter your shipping information

Personal information


Personal data marked with an asterisk (*) are essential to provide our service to you and must be filled out.

Stock chart